StockData

Acro Biomedical Co., Ltd. (ACBM) stock

ACBMOTCServices-Amusement & Recreation ServicesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.56MP/E –Yield –

Acro Biomedical operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Acro Biomedical's operating cash flow for the twelve months ending Jun 30, 2026 was -$140.11K. For fiscal 2025 it was -$196.30K. The highest annual figure on record is $299.34K in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$196.30K–
FY2024Dec 31, 2024-$36.69K–
FY2023Dec 31, 2023-$15.45K–
FY2022Dec 31, 2022-$147.48K-149.3%
FY2021Dec 31, 2021$299.34K+275.6%
FY2019Sep 30, 2019$79.69K–
FY2018Sep 30, 2018-$140.42K–
FY2017Sep 30, 2017-$463.34K–
FY2016Sep 30, 2016-$34.74K–
FY2015Sep 30, 2015-$48.85K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026-$10.50K–
Q1 FY2026CQ1 2026Mar 31, 2026-$49.82K–
Q4 FY2025CQ4 2025Dec 31, 2025-$25.38K–
Q3 FY2025CQ3 2025Sep 30, 2025-$54.41K–
Q2 FY2025CQ2 2025Jun 30, 2025-$93.98K–
Q1 FY2025CQ1 2025Mar 31, 2025-$22.53K–
Q4 FY2024CQ4 2024Dec 31, 2024-$10.52K–
Q3 FY2024CQ3 2024Sep 30, 2024-$6.34K-1411.6%
Q2 FY2024CQ2 2024Jun 30, 2024-$6.33K-381.3%
Q1 FY2024CQ1 2024Mar 31, 2024-$13.51K–
Q4 FY2023CQ4 2023Dec 31, 2023-$12.61K–
Q3 FY2023CQ3 2023Sep 30, 2023$483–
Q2 FY2023CQ2 2023Jun 30, 2023$2.25K–
Q1 FY2023CQ1 2023Mar 31, 2023-$5.57K-102.1%
Q4 FY2022CQ4 2022Dec 31, 2022-$10.57K–
Q3 FY2022CQ3 2022Sep 30, 2022-$53.27K–
Q2 FY2022CQ2 2022Jun 30, 2022-$345.78K-179.9%
Q1 FY2022CQ1 2022Mar 31, 2022$262.13K–
Q4 FY2021CQ4 2021Dec 31, 2021-$60.51K-241.1%
Q3 FY2021CQ3 2021Sep 30, 2021-$64.55K–
Q2 FY2021CQ2 2021Jun 30, 2021$432.77K–
Q1 FY2021CQ1 2021Mar 31, 2021-$8.38K-104.8%
Q4 FY2019CQ3 2019Sep 30, 2019$42.87K–
Q3 FY2019CQ2 2019Jun 30, 2019-$85.18K–
Q2 FY2019CQ1 2019Mar 31, 2019-$52.34K-112.8%
Q1 FY2019CQ4 2018Dec 31, 2018$174.33K–
Q4 FY2018CQ3 2018Sep 30, 2018-$4.17K–
Q3 FY2018CQ2 2018Jun 30, 2018-$512.36K–
Q2 FY2018CQ1 2018Mar 31, 2018$409.37K–
Q1 FY2018CQ4 2017Dec 31, 2017-$33.26K–
Q4 FY2017CQ3 2017Sep 30, 2017-$416.18K–
Q3 FY2017CQ2 2017Jun 30, 2017-$17.55K–
Q2 FY2017CQ1 2017Mar 31, 2017-$29.47K–
Q1 FY2017CQ4 2016Dec 31, 2016-$142–
Q4 FY2016CQ3 2016Sep 30, 2016-$9.61K–
Q3 FY2016CQ2 2016Jun 30, 2016-$5.60K–
Q2 FY2016CQ1 2016Mar 31, 2016-$8.17K–
Q1 FY2016CQ4 2015Dec 31, 2015-$11.37K–
Q4 FY2015CQ3 2015Sep 30, 2015-$1.52K–
Q3 FY2015CQ2 2015Jun 30, 2015-$2.20K–

More Acro Biomedical figures

See a number that looks wrong?